-
Novel Allosteric PDK4 Inhibitors for Metabolic Disease
2026-08-15
Lee and colleagues used anthraquinone-based structural optimization to identify compound 8c, a potent allosteric PDK4 inhibitor with activity in biochemical, metabolic, allergic, and cancer-related models. The study supports the lipoamide-binding site as a tractable design region while also showing why pharmacokinetic, mechanistic, and disease-model data must be interpreted together.
-
PXDN, LDHA, and Glycolysis in Glioblastoma
2026-08-14
The reference study integrates transcriptomic network analysis with cellular and in vivo experiments to identify peroxidasin (PXDN) as a glycolysis-associated driver of glioblastoma progression. Its knockdown and LDHA-rescue results support a PXDN–LDHA axis that links metabolic reprogramming with malignant behavior, while also defining important directions for validation in patient-derived models.
-
Cy5 amine (non-sulfonated) Labeling Guide
2026-08-14
Cy5 amine (non-sulfonated) is a primary-amine cyanine reagent for covalent labeling of activated proteins, peptides, polymers, and related biomolecules. Because it is insoluble in water, it must first be dissolved in an organic co-solvent; it is intended for research workflows such as fluorescence microscopy and flow cytometry, not direct aqueous use or diagnostic applications.
-
Measuring Cancer Drug Response Beyond Viability
2026-08-13
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that conventional in vitro drug-response assays can conflate proliferative arrest with cell killing. This framework has practical consequences for interpreting DNA damage response inhibition, cell cycle checkpoint abrogation, and responses to agents such as Wee1 kinase inhibitors.
-
Humanized Gs-DREADD for Neural Circuit Modulation
2026-08-13
Zhang and colleagues developed hM3Ds, a whole-sequence-humanized Gs-coupled DREADD, and showed that it retained a ligand-response profile comparable to the non-human rM3Ds receptor. Selective expression in D1 medium spiny neurons activated the basal ganglia direct pathway and improved Parkinsonian phenotypes in mice, supporting hM3Ds as a useful research tool while leaving clinical safety questions unresolved.
-
Z-VAD-FMK for Apoptosis Assays
2026-08-12
Use Z-VAD-FMK to test whether a treatment-induced phenotype is caspase dependent, rather than merely observing a loss of viability. This workflow connects inhibitor rescue experiments with cell-cycle, apoptotic, and signaling readouts in resistant cancer models.
-
Sulfisomidine: From PK to Assay Design
2026-08-12
Sulfisomidine is a dual-purpose biochemical probe whose antibacterial mechanism and mixed-type hPON1 inhibition can inform better assay design. This article connects historical exposure data with modern enzyme kinetics, microbial metabolism, and environmental study workflows.
-
Paclitaxel (Taxol) Workflows for Cancer Research
2026-08-11
Build reproducible Paclitaxel assays around mitotic arrest, microtubule stabilization, and apoptosis rather than relying on endpoint viability alone. The workflow also shows how Taxol can serve as a chemotherapy stress arm in multi-node PI3K/AKT/mTOR experiments and advanced tumor models.
-
KPT-330: From Nuclear Export to Translation
2026-08-11
KPT-330, also known as Selinexor, offers translational researchers a mechanistically coherent way to study CRM1-dependent nuclear export, tumor suppressor retention, apoptosis, and cell-cycle control. This thought-leadership guide connects oncology evidence with emerging osteoarthritis findings while outlining practical workflows, competitive considerations, and limits on cross-indication interpretation.
-
Z-YVAD-FMK: Reading Caspase-1 in Cell Death
2026-08-10
Discover how Z-YVAD-FMK, a cell-permeable caspase-1 inhibitor, can separate inflammatory caspase signaling from apoptosis and necroptosis. This evidence-led guide translates ricin bystander-cell findings into practical assay and interpretation strategies.
-
Netarsudil (AR-13324) siRNA Workflow Guide
2026-08-09
Netarsudil (AR-13324) combines potent ROCK pathway inhibition with a distinctive opportunity for siRNA codelivery in trabecular meshwork models. This bench-focused guide translates predictive nanoparticle findings into practical formulation, cell-based assay, control, and troubleshooting decisions.
-
Decitabine Priming and PD-1 Blockade in Tumors
2026-08-08
Li et al. show that low-dose decitabine can improve anti–PD-1 therapy by expanding and functionally sustaining CD8+ progenitor exhausted T cells rather than simply increasing global T-cell activation. The study connects this effect to preservation of JunD-dependent AP-1 activity and provides a mechanistic framework for combining epigenetic priming with checkpoint blockade in tumor models.
-
PDE-5-Inhibited BMSCs in Diabetic Myocardial Fibrosis
2026-08-07
The reference study reports that bone marrow mesenchymal stem cells with silenced PDE-5 reduce high glucose-associated myocardial fibrosis and cardiomyocyte apoptosis while increasing cGMP/PKG signaling. Its main contribution is to connect BMSC engineering with a defined cardioprotective pathway, although the in vitro design limits direct translation to diabetic cardiomyopathy treatment.
-
Peroxidasin Drives Glycolytic Reprogramming in Glioblastoma
2026-08-07
This study identifies peroxidasin (PXDN) as a central regulator of glycolytic metabolism in glioblastoma, acting through the upregulation of LDHA to promote malignancy. These findings provide mechanistic insight into metabolic reprogramming in GBM and nominate PXDN as a potential diagnostic and therapeutic target.
-
Optimizing Pyroptosis Research with Caspase-4 Colorimetric A
2026-08-06
This article provides scenario-driven, evidence-based guidance for biomedical researchers using the Caspase-4 Colorimetric Assay Kit (SKU K2199) in cell viability, proliferation, and cytotoxicity workflows. It addresses real laboratory challenges—from assay design to vendor selection—while grounding recommendations in validated protocols and quantitative performance data. Readers gain actionable insights on leveraging SKU K2199 for reliable detection of LEVD-dependent caspase-4 activity.